Innovative Eyewear Inc LUCY
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 2022-08-12
Innovative Eyewear Inc financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.7M | $1.6M | $1.2M | $659,788 | $690,670 |
| Gross profit | $567,451 | $215,190 | -$119,329 | -$56,289 | $148,254 |
| R&D expense | $725,388 | $819,387 | $662,184 | $524,692 | $86,261 |
| Interest expense | — | — | $3,036 | $105,171 | $39,433 |
| Net income | -$7.6M | -$7.8M | -$6.7M | -$5.7M | -$3.2M |
| EPS (diluted) | $-1.90 | $-5.19 | $-10.87 | $-0.87 | — |
| Operating cash flow | -$7.3M | -$6.7M | -$5.8M | -$3.2M | -$1.2M |
| Free cash flow | -$7.3M | -$6.8M | -$5.8M | -$3.3M | -$1.2M |
| Cash & equivalents | $6.5M | $2.6M | $4.3M | $3.6M | $79,727 |
| Inventory | $1.7M | $831,757 | $533,239 | $94,701 | $275,501 |
| Total assets | $10.1M | $9.8M | $6.2M | $4.7M | $824,317 |
| Total liabilities | $1.1M | $743,168 | $659,936 | $665,455 | $616,801 |
| Shareholders' equity | $9.1M | $9.1M | $5.6M | $4.0M | $207,516 |
Source: SEC EDGAR filings · CIK 0001808377 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.